ATE456655T1 - Behandlungsverfahren unter verwendung von wisp- polypeptiden - Google Patents

Behandlungsverfahren unter verwendung von wisp- polypeptiden

Info

Publication number: ATE456655T1
Authority: AT; Austria
Prior art keywords: administration; cartilage; treatment; injury; repair
Prior art date: 2000-10-16

Application number

AT08001040T

Other languages

English (en)

Inventor

Luc Desnoyer

Ellen H Filvaroff

Diane Pennica

Original Assignee

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-16

Filing date

2001-10-12

Publication date

2010-02-15

2001-10-12 Application filed by Genentech Inc filed Critical Genentech Inc

2010-02-15 Application granted granted Critical

2010-02-15 Publication of ATE456655T1 publication Critical patent/ATE456655T1/de

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
238000000034 method Methods 0.000 title abstract 4
229920001184 polypeptide Polymers 0.000 title abstract 4
102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
210000000845 cartilage Anatomy 0.000 abstract 5
208000027418 Wounds and injury Diseases 0.000 abstract 3
230000006378 damage Effects 0.000 abstract 3
230000003412 degenerative effect Effects 0.000 abstract 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
208000014674 injury Diseases 0.000 abstract 3
239000005557 antagonist Substances 0.000 abstract 1
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
206010003246 arthritis Diseases 0.000 abstract 1
230000015556 catabolic process Effects 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
210000001612 chondrocyte Anatomy 0.000 abstract 1
239000003102 growth factor Substances 0.000 abstract 1
238000001356 surgical procedure Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Toxicology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

AT08001040T 2000-10-16 2001-10-12 Behandlungsverfahren unter verwendung von wisp- polypeptiden ATE456655T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US24122200P	2000-10-16	2000-10-16

Publications (1)

Publication Number	Publication Date
ATE456655T1 true ATE456655T1 (de)	2010-02-15

Family

ID=22909763

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
AT10000199T ATE544855T1 (de)	2000-10-16	2001-10-12	Wisp polypeptide, und deren therapeutische anwendungen
AT08001040T ATE456655T1 (de)	2000-10-16	2001-10-12	Behandlungsverfahren unter verwendung von wisp- polypeptiden
AT01987803T ATE389719T1 (de)	2000-10-16	2001-10-12	Behandlungsverfahren mit wisp-polypeptiden

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AT10000199T ATE544855T1 (de)	2000-10-16	2001-10-12	Wisp polypeptide, und deren therapeutische anwendungen

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT01987803T ATE389719T1 (de)	2000-10-16	2001-10-12	Behandlungsverfahren mit wisp-polypeptiden

Country Status (10)

Country	Link
US (2)	US7687460B2 (de)
EP (3)	EP1927659B1 (de)
JP (1)	JP4202128B2 (de)
AT (3)	ATE544855T1 (de)
AU (2)	AU2437702A (de)
CA (1)	CA2425145C (de)
DE (2)	DE60133301T2 (de)
ES (3)	ES2304401T3 (de)
IL (3)	IL155279A0 (de)
WO (1)	WO2002033085A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2304401T3 (es) *	2000-10-16	2008-10-16	Genentech, Inc.	Metodos de tratamiento que utilizan polipeptidos wisp.
US20060292150A1 (en) *	2003-09-11	2006-12-28	Luc Desnoyers	Methods of using wisp antagonists
SE0401069D0 (sv) *	2004-04-26	2004-04-26	Anamar Medical Ab	Use of Compounds for the Treatment of Diseases and Conditions
AU2007261530B2 (en) *	2006-06-20	2014-02-06	Genzyme Corporation	Serum-free media and their uses for chondrocyte expansion
EP2147311A4 (de) *	2007-04-26	2010-08-11	Genera Istrazivanja D O O	Blut-biomarker für knochenbruch und knorpelverletzung
AU2009234338B2 (en)	2008-01-18	2014-07-24	Burnham Institute For Medical Research	Methods and compositions related to internalizing RGD peptides
BRPI1015424B1 (pt)	2009-06-22	2022-01-18	Burnham Institute For Medical Research	Composição compreendendo um elemento cendr e uma co-composição e composição para uso no reforço da internalização, penetração, ou ambas, de uma co-composição
PL2453921T3 (pl)	2009-07-14	2015-11-30	Scripps Research Inst	Różnicowanie mezenchymalnych komórek macierzystych
EP2671079B1 (de) *	2011-01-31	2018-12-26	Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd.	Snx9 als neue biomarker für chronische entzündungen und zugehörige immunosuppression sowie ein neuer regulator der t-zell-rezeptorexpression und funktion
MX366804B (es)	2012-02-11	2019-07-25	Genentech Inc	Translocaciones de la r-espondina y sus metodos de uso.
US9301971B2 (en)	2013-03-08	2016-04-05	Novartis Ag	Peptides and compositions for treatment of joint damage
UY35368A (es)	2013-03-08	2014-10-31	Irm Llc	Péptidos y composiciones para el tratamiento de daño articular
AU2017207445B2 (en) *	2016-01-14	2023-12-07	Spinalcyte, Llc	Cellular blend for the regeneration of chondrocytes or cartilage type cells
JP2019527193A (ja) *	2016-06-02	2019-09-26	ソシエテ・デ・プロデュイ・ネスレ・エス・アー	サルコペニア及び筋損傷を治療する方法
AR116566A1 (es)	2018-10-03	2021-05-19	Novartis Ag	Administración sostenida de polipéptidos similares a la angiopoyetina 3
EP3711772A1 (de) *	2019-03-20	2020-09-23	Oslo Universitetssykehus HF	Rekombinante proteine und fusionsproteine
KR102167443B1 (ko) *	2019-03-25	2020-10-19	주식회사 카티프라임	체외 골관절염 모델 및 이를 이용한 골관절염 치료제 스크리닝 방법
CN111700881B (zh) *	2020-07-02	2021-05-18	四川大学	Wnt蛋白＼ZIF-8纳米复合体、其制备方法及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5364839A (en)	1990-06-18	1994-11-15	Genetics Institute, Inc.	Osteoinductive pharmaceutical formulations
US5206023A (en)	1991-01-31	1993-04-27	Robert F. Shaw	Method and compositions for the treatment and repair of defects or lesions in cartilage
US5408040A (en) *	1991-08-30	1995-04-18	University Of South Florida	Connective tissue growth factor(CTGF)
WO1995017416A1 (en)	1993-12-22	1995-06-29	Merck & Co., Inc.	Dna encoding the wnt-x growth factor
US5444047A (en) *	1994-06-16	1995-08-22	Dipasquale; Gene	Treatment of arthritic and post-surgical orthopedic conditions with Insulin-like Growth Factor-I
ES2246056T3 (es)	1996-11-08	2006-02-01	Human Genome Sciences, Inc.	Factor 3 de crecimiento de tejido conjuntivo.
CA2294564A1 (en) *	1997-06-19	1998-12-23	Incyte Pharmaceuticals, Inc.	Polynucleotides encoding a growth factor-like protein
US20020192209A1 (en) *	1997-09-17	2002-12-19	Genentech, Inc.	Methods and compositions for inhibiting neoplastic cell growth
IL135704A (en) *	1997-10-29	2008-04-13	Genentech Inc	Method of diagnosing neoplastic cell growth by detection of the wnt-1 induced secreted polypeptide wisp-1
AU4411499A (en) *	1998-06-05	1999-12-20	Human Genome Sciences, Inc.	Connective tissue growth factor-4
AU2600800A (en) *	1999-03-08	2000-09-28	Genentech Inc.	Promotion or inhibition of angiogenesis and cardiovascularization
KR100342045B1 (ko) *	1999-04-16	2002-06-27	김순택	2차전지
WO2001007085A1 (en)	1999-07-23	2001-02-01	Case Western Reserve University	Novel methods and reagents useful in the treatment of osteoarthritis
GB9930768D0 (en)	1999-12-29	2000-02-16	Pfizer Ltd	Composition
US20020063763A1 (en) *	2000-11-29	2002-05-30	Mantell David Allen	Apparatus and method for removing air bubbles from an ink jet printhead
US6812339B1 (en) *	2000-09-08	2004-11-02	Applera Corporation	Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
ES2304401T3 (es) *	2000-10-16	2008-10-16	Genentech, Inc.	Metodos de tratamiento que utilizan polipeptidos wisp.

2001
- 2001-10-12 ES ES01987803T patent/ES2304401T3/es not_active Expired - Lifetime
- 2001-10-12 AT AT10000199T patent/ATE544855T1/de active
- 2001-10-12 IL IL15527901A patent/IL155279A0/xx unknown
- 2001-10-12 AU AU2437702A patent/AU2437702A/xx active Pending
- 2001-10-12 ES ES10000199T patent/ES2381935T3/es not_active Expired - Lifetime
- 2001-10-12 DE DE60133301T patent/DE60133301T2/de not_active Expired - Lifetime
- 2001-10-12 DE DE60141236T patent/DE60141236D1/de not_active Expired - Lifetime
- 2001-10-12 AT AT08001040T patent/ATE456655T1/de active
- 2001-10-12 AT AT01987803T patent/ATE389719T1/de active
- 2001-10-12 EP EP08001040A patent/EP1927659B1/de not_active Expired - Lifetime
- 2001-10-12 EP EP10000199A patent/EP2180053B1/de not_active Expired - Lifetime
- 2001-10-12 EP EP01987803A patent/EP1326980B1/de not_active Expired - Lifetime
- 2001-10-12 US US10/399,093 patent/US7687460B2/en not_active Expired - Fee Related
- 2001-10-12 WO PCT/US2001/032142 patent/WO2002033085A2/en not_active Ceased
- 2001-10-12 CA CA2425145A patent/CA2425145C/en not_active Expired - Fee Related
- 2001-10-12 JP JP2002536453A patent/JP4202128B2/ja not_active Expired - Fee Related
- 2001-10-12 AU AU2002224377A patent/AU2002224377B2/en not_active Ceased
- 2001-10-12 ES ES08001040T patent/ES2338492T3/es not_active Expired - Lifetime
2003
- 2003-04-08 IL IL155279A patent/IL155279A/en not_active IP Right Cessation
2009
- 2009-08-07 US US12/537,888 patent/US8138152B2/en not_active Expired - Fee Related
- 2009-08-19 IL IL200484A patent/IL200484A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU2002224377B8 (en)	2002-04-29
EP2180053A2 (de)	2010-04-28
AU2437702A (en)	2002-04-29
EP2180053B1 (de)	2012-02-08
IL155279A (en)	2011-05-31
ATE389719T1 (de)	2008-04-15
CA2425145A1 (en)	2002-04-25
AU2002224377B2 (en)	2007-07-19
WO2002033085A3 (en)	2003-04-17
ES2338492T3 (es)	2010-05-07
US8138152B2 (en)	2012-03-20
US20100093628A1 (en)	2010-04-15
CA2425145C (en)	2011-08-30
IL200484A0 (en)	2010-04-29
WO2002033085A9 (en)	2002-07-25
ES2381935T3 (es)	2012-06-01
EP1927659A1 (de)	2008-06-04
US20050054563A1 (en)	2005-03-10
DE60133301D1 (de)	2008-04-30
DE60141236D1 (de)	2010-03-18
JP4202128B2 (ja)	2008-12-24
EP1326980B1 (de)	2008-03-19
EP2180053A3 (de)	2010-11-10
DE60133301T2 (de)	2009-05-14
ES2304401T3 (es)	2008-10-16
ATE544855T1 (de)	2012-02-15
IL155279A0 (en)	2003-11-23
US7687460B2 (en)	2010-03-30
JP2004534720A (ja)	2004-11-18
EP1326980A2 (de)	2003-07-16
EP1927659B1 (de)	2010-01-27
IL200484A (en)	2012-05-31
WO2002033085A2 (en)	2002-04-25

Legal Events

Date

Code

Title

Description

2010-08-15

UEP

Publication of translation of european patent specification

Ref document number: 1927659

Country of ref document: EP

Publication	Publication Date	Title
IL200484A0 (en)	2010-04-29	Use of wisp polypeptides wisp for the preparation of medicaments
ATE328605T1 (de)	2006-06-15	Verwendung von insulin zur behandlung von knorpelkrankheiten
ATE362766T1 (de)	2007-06-15	Apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dislipidemischer erkrankungen
DK0968012T3 (da)	2006-12-27	Osteogene indretninger og fremgangsmåder til anvendelse deraf til reparation af knogler
DE69729125D1 (de)	2004-06-17	Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese
ATE258984T1 (de)	2004-02-15	Bmp-11 zusammensetzungen
ATE265529T1 (de)	2004-05-15	Bmp-10 zusammensetzungen
PT733109E (pt)	2006-07-31	Proteinas morfogeneticas dos 0ss0s pmo-12 e pmo-13 e as suas composicoes para inducao de tendao
ES2088006T3 (es)	1996-08-01	Composiciones farmaceuticas osteoinductivas.
ATE218579T1 (de)	2002-06-15	Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin- analogen
EA200400734A1 (ru)	2004-12-30	Способ и композиция для потенциирования действия опиатного анальгетика
DE69940206D1 (de)	2009-02-12	Verfahren zur behandlung von multiplem myelom und von myelom- induzierter knochenresorption mit antagonisten der integrin-/rezeptorbindung
DE69821793D1 (de)	2004-03-25	Neuronale verwendungen des bmp-11
EA199900522A1 (ru)	2000-02-28	Полипептиды, кодируемые геном, подобным гену липазы человека, композиции и методы
IT1293305B1 (it)	1999-02-16	Sali di acidi difosfonici e loro impiego farmacologico nel trattamento dell'osteoporosi
DE69808475D1 (de)	2002-11-07	Aminosäurederivate zur behandlung von schlaganfall
ATE501730T1 (de)	2011-04-15	Verfahren zur behandlung von psoriasis unter verwendung eines il-17d antagonisten
ITTO960041A0 (it)	1996-01-25	Macchina semovente per la stabilizzazione, mediante martellinatura e compattazione, di binari posati su massicciata.
DK1074264T3 (da)	2008-11-24	Inhibitorer for neovaskularisering
DE69941134D1 (de)	2009-08-27	Verwendung von R (+)- g(a)-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol zur Behandlung von Schlafstörungen